Searched for
COVID THERAPY
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Over 1,500 bat species carry thousands of deadly viruses but rarely get sick, and scientists are only just beginning to understand whyBats possess a unique, preactivated innate immune defense that stops viruses from fully replicating, even after cell entry. This remarkable...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Why travellers are turning to the zodiac for vacation planningPeople are increasingly using astrocartography to guide major life choices. This practice, which maps planetary influences on locations, he...
- Woman felt strange sensation in legs for 6 months, pain was worse at night while lying down. Hyderabad Neurologist reveals what went wrongDR Sudhir Kumar, a Hyderabad-based neurologist at Apollo Hospitals, revealed a case in which a woman experienced strange pain in her legs f...
- Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiativeRegeneron will reduce prices for its drugs on Medicaid. A cholesterol drug, Praluent, will be available for USD 225 on Trump's discounted d...
- Capital with purpose: How capital markets are shaping the future of medicine with Dheeraj ChinthalapellyDheeraj Chinthalapelly, with a decade and a half of experience in global capital markets, shares his journey navigating the biotech investm...
- ‘Cicada’ Covid variant with 75 mutations is spreading: What it means for youCicada Covid Variant Symptoms: A new COVID variant with 70-75 spike protein mutations has been detected. The new virus can potentially evad...
- USFDA revokes emergency use status to two Covid antibody therapies"Because data show these treatments are highly unlikely to be active against the omicron variant, which is circulating at a very high frequ...
- Good news on Covid therapy frontExperience with the Omicron variant so far makes clear that while vaccines are critical for reducing the virulence of the disease, therapie...
- India drops plasma therapy from COVID-19 management guidelinesExperts at the ICMR had been reviewing the available data and had not found any benefit. “The recovery trial document was examined and show...
- Blood plasma reduces risk of severe COVID-19 if given earlyThey arrive nearly five months after the Food and Drug Administration, under pressure from President Donald Trump, issued the therapy an em...
- AIIMS planning to conduct clinical trial of plasma therapyAIIMS Director Dr Randeep Guleria said the mode of treatment in COVID-19 is still at an "experimental stage" and there is a need for good a...
- Convalescent plasma therapy can create life-threatening complications: Govt"ICMR has launched a national-level study to study efficacy of plasma therapy in treatment of COVID 19,"said Lav Agarwal.
- Initial results of plasma therapy trial conducted on 4 COVID-19 patients encouraging: KejriwalAddressing an online media briefing, Kejriwal said the government will conduct more clinical trials of plasma therapy in the next two-three...
Load More
